WCM
GSK icon

Winthrop Capital Management’s GSK GSK Stock Holding History

Winthrop Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Hold
3,978
– – 0.06% 118
2025
Q4 		$195K Buy
3,978
+107
+3% +$4.99K 0.05% 128
2025
Q3 		$167K Buy
+3,871
New +$151K 0.04% 124

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Winthrop Capital Management's GSK Position: Q1 2026 in Review

Winthrop Capital Management held its GSK (GSK) position steady in Q1 2026 at 3,978 shares worth $220K. The position accounts for 0.06% of the portfolio, ranked #118.

Winthrop Capital Management first reported a position in GSK in Q3 2025 and has held it in 3 quarters since. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Winthrop Capital Management held 3,978 shares of GSK worth $220K as of Q1 2026.
  • Winthrop Capital Management left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.06% of Winthrop Capital Management's portfolio in Q1 2026, its #118 holding.
  • Winthrop Capital Management first reported a position in GSK in Q3 2025 and has held it in 3 quarters since.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.